COMMISSION IMPLEMENTING REGULATION (EU) 2017/856 | 32017R0856 — European Union law | Esheria

COMMISSION IMPLEMENTING REGULATION (EU) 2017/856

This regulation amends the fluroxypyr approval conditions, sets a maximum NMP impurity level, and gives Member States deadlines for changing or ending product authorisations and grace periods.

Jurisdiction
European Union
Instrument
Regulation
Citation
32017R0856
Status
In force
Version
Undated source snapshot
Language
en
Official source
View official record ↗
authorisation withdrawal grace periods impurity limits product approval conditions

Statute overview

About this statute

This page preserves the statute’s identified version, provision structure, official source link, and stored legal text for reading and research.

LexChat organizes source-backed legal information for research. Verify amendments, commencement, and current legal force with the official publisher before relying on it.